WallStSmart

eGain Corporation (EGAN)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 185% more annual revenue ($258.90M vs $90.73M). EGAN leads profitability with a 39.8% profit margin vs -15.5%. EGAN earns a higher WallStSmart Score of 67/100 (B-).

EGAN

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 8.0Value: 7.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EGANOvervalued (-14.8%)

Margin of Safety

-14.8%

Fair Value

$8.56

Current Price

$7.56

$1.00 premium

UndervaluedFair: $8.56Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EGAN6 strengths · Avg: 9.3/10
P/E RatioValuation
5.9x10/10

Attractively priced relative to earnings

Return on EquityProfitability
50.1%10/10

Every $100 of equity generates 50 in profit

Profit MarginProfitability
39.8%10/10

Keeps 40 of every $100 in revenue as profit

EPS GrowthGrowth
300.0%10/10

Earnings expanding 300.0% YoY

PEG RatioValuation
0.998/10

Growing faster than its price suggests

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

EGAN2 concerns · Avg: 3.5/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Market CapQuality
$204.85M3/10

Smaller company, higher risk/reward

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : EGAN

The strongest argument for EGAN centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 39.8% and operating margin at 8.9%. PEG of 0.99 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : EGAN

The primary concerns for EGAN are Revenue Growth, Market Cap.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

EGAN profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

EGAN scores higher overall (67/100 vs 41/100), backed by strong 39.8% margins. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

eGain Corporation

TECHNOLOGY · SOFTWARE - APPLICATION · USA

eGain Corporation is a software-as-a-service provider of customer engagement solutions in the United States, the United Kingdom, India, and internationally. The company is headquartered in Sunnyvale, California.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?